FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 48 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $60,285 | -18.1% | 153,397 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $73,631 | -88.7% | 153,397 | -60.5% | 0.01% | -86.5% |
| Q3 2022 | $649,000 | -41.2% | 388,691 | 0.0% | 0.05% | -23.5% |
| Q2 2022 | $1,104,000 | -43.5% | 388,691 | 0.0% | 0.07% | -35.8% |
| Q1 2022 | $1,955,000 | -83.2% | 388,691 | -66.7% | 0.11% | -17.2% |
| Q4 2021 | $11,625,000 | +130.1% | 1,166,073 | +200.0% | 0.13% | -16.3% |
| Q3 2021 | $5,053,000 | +52.6% | 388,691 | +65.2% | 0.15% | +77.9% |
| Q2 2021 | $3,311,000 | -47.3% | 235,294 | -39.5% | 0.09% | -63.9% |
| Q1 2021 | $6,277,000 | – | 388,691 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |